Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
KNBWY | OTC Markets | USD | Delayed | |
KNBWF | OTC Markets | USD | Delayed | |
2503 | Tokyo | JPY | Delayed |
Kirin Holdings Company, Limited engages in food and beverages, pharmaceuticals, and health science businesses. The company’s products include beer, wine, whiskey, spirits, soft drinks, dairy products, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products. In addition, the company engages in the factories and theme park businesses; management and operation of a chain of Kirin City beer pubs; and manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals, as well as margarine, jams, and honey. Further, it is involved in the manufacture and sale of Coca-Cola products and other soft drinks; manufacture of Four Roses bourbon; transport logistic services; shared services, such as accounting, human resources, and real estate; Internal information system development; sales of feed; insurance agent; and sales of the supplements; research, development, manufacture, and sale of cosmetics and health foods. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Yoshinori Isozaki | 69 | 2010 | President, CEO & Representative Director |
Keisuke Nishimura | 67 | 2015 | Senior EVP & Representative Director |
Chieko Matsuda | 59 | 2016 | Independent Outside Director |
George C. Olcott | 68 | 2020 | Independent Outside Director |
Kaoru Kashima | 65 | 2020 | Audit & Supervisory Board Member |
Hiroyuki Yanagi | 69 | 2019 | Independent Outside Director |
Kenichi Fujinawa | 68 | 2022 | Audit & Supervisory Board Member |
Noriko Shiono | 63 | 2020 | Independent Outside Director |
Yoshiko Ando | 64 | 2019 | Outside Audit & Supervisory Board Member |
Shinya Katanozaka | 68 | 2023 | Independent Outside Director |
Shobu Nishitani | 60 | 2022 | Standing Audit & Supervisory Board Member |
Roderick Ian Eddington | 73 | 2020 | Independent Outside Director |
Takeshi Minakata | 62 | 2020 | Senior Executive Officer, President of the Health Science Division & Director |
Junko Tsuboi | 61 | 2019 | Director, Senior Executive Officer & GM of Strategic Branding Department |
Toru Ishikura | 60 | 2022 | Exe. Off, GM of Health Sci Bus Dev & Health Science Bus Div and Full-time Audit & Sup Board Mem |
Masakatsu Mori | 77 | 2015 | Independent Chairman of the Board |
Toshiya Miyoshi | 66 | 2015 | Senior Executive Officer & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review